secwatch.observer — SEC 8-K summary
======================================

Issuer:     Gossamer Bio, Inc. (GOSS)
CIK:        0001728117
Form:       8-K
Filed at:   2022-07-13T23:59:59+00:00
Accession:  0001728117-22-000057
Event type: other_material
Sentiment:  positive
Materiality: 0.70
Item codes: 1.01, 3.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Gossamer Bio raises $120M via private placement of 16.6M shares at $7.21/share
------------------------------------------------------------------------------

- Private placement of 16.6M shares at $7.21; gross proceeds ~$120M before expenses.
- Participation by EcoR1 Capital, NEA, Weiss Asset Management, Rock Springs Capital, and others.
- Proceeds to fund seralutinib R&D ahead of Phase 2 TORREY topline results in Q4 2022.
- Expected close July 15, 2022; lock-up on shares until October 1, 2022.
- Cash runway extended into mid-2024 with existing cash and debt facility.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1728117/000172811722000057/0001728117-22-000057-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1728117/000172811722000057/goss-20220713.htm
  HTML page:      https://secwatch.observer/filing/0001728117-22-000057

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer